Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China · Delayed Price · Currency is CNY

12.30

+0.20 (1.65%)

Sep 30, 2026, 3:00 PM CST

Market Cap	6.96B -17.8%
Revenue (ttm)	3.31B +1.0%
Net Income	308.72M +4.1%
EPS	0.55 +6.0%
Shares Out	566.16M
PE Ratio	22.36
Forward PE	20.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,021,800
Open	12.10
Previous Close	12.10
Day's Range	12.05 - 12.37
52-Week Range	10.69 - 16.61
Beta	0.41
Analysts	Strong Buy
Price Target	15.66 (+27.32%)
Earnings Date	Oct 30, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals. The company offers Chinese medicine for anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. It also provides herb extracts and formula granules, well as OEM/ODM services. The company was founded in 1975 and is based in Lianyungang, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1975

Employees 5,379

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600557

Full Company Profile

Financial Performance

In 2025, SHA:600557's revenue was 3.29 billion, a decrease of -15.52% compared to the previous year's 3.90 billion. Earnings were 303.93 million, a decrease of -22.44%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 600557 stock is "Strong Buy." The 12-month stock price target is ¥15.66, which is an increase of 27.32% from the latest price.

Price Target

¥15.66

(27.32% upside)

Analyst Consensus: Strong Buy

Stock Forecasts